Odyssey Health (ODYY) Receivables (2016 - 2024)

Odyssey Health's (ODYY) quarterly Receivables came in at $22625.0 in Q3 2024, up 2050.67% quarter-over-quarter from $1052.0 in Q4 2017.

Odyssey Health (ODYY) Receivables (2016 - 2024) Analysis & Trends

Odyssey Health's Receivables history runs 3 years deep, the most recent figure standing at $22625.0 for Q3 2024.

On a quarterly basis, Receivables changed N/A year-over-year to $22625.0 in Q3 2024; TTM through Jul 2024 was $22625.0, a N/A change from a year earlier, with the FY2024 full-year figure at -$231316.0, changed N/A from the prior year.
Receivables rose to $22625.0 in Q3 2024 per ODYY's latest filing, from $1052.0 in the prior quarter.
Across five years, Receivables topped out at $22625.0 in Q3 2024 and bottomed at $22625.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	8.21 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	3.57 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	6.64 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	3.03 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	973.00 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	1.11 Bn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	3.80 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	4.50 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	1.55 Bn
10	Odyssey Health	1.08 Mn	782,508.17	-	-

Download Data